Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
279.98
96.31
65.03
99.89
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
279.98
96.31
65.03
99.89
0.00
0.00
0.00
Raw Material Cost
93.56
70.36
68.62
70.18
27.41
25.17
13.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
77.98
93.94
116.17
107.66
76.56
77.85
48.56
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.44
10.58
8.36
2.90
4.43
8.73
5.31
Selling and Distribution Expenses
244.09
126.81
107.98
87.11
56.41
55.08
39.46
Other Expenses
-1.73
1.73
2.70
19.06
4.44
5.67
4.81
Total Expenditure (Excl Depreciation)
409.73
319.03
328.13
458.47
209.25
223.54
155.29
Operating Profit (PBDIT) excl Other Income
-129.8
-222.7
-263.09999999999997
-358.6
-209.20000000000002
-223.5
-155.29999999999998
Other Income
2.18
2.06
25.97
9.86
6.21
33.83
10.81
Operating Profit (PBDIT)
-61.08
-153.59
-177.18
-295.84
-175.63
-164.54
-130.61
Interest
11.44
10.58
8.36
2.90
4.43
8.73
5.31
Exceptional Items
0.29
-0.09
0.33
0.00
0.00
-31.21
0.00
Gross Profit (PBDT)
186.42
25.96
-3.60
29.71
-27.41
-25.17
-13.88
Depreciation
66.49
67.07
59.95
52.88
27.41
25.17
13.88
Profit Before Tax
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
-180.74
Tax
0.00
0.00
0.00
0.00
0.00
0.00
-3.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
-147.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
-147.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-29.46
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
-177.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
94.64
225.77
450.16
736.38
1,045.12
1,178.68
284.60
Earnings per share (EPS)
-0.03
-0.06
-0.06
-0.09
-0.05
-0.06
-0.04
Diluted Earnings per share
-0.03
-0.06
-0.06
-0.09
-0.05
-0.06
-0.04
Operating Profit Margin (Excl OI)
-46.34%
-231.25%
-404.61%
-358.97%
0.0%
0.0%
0.0%
Gross Profit Margin
-25.8%
-170.56%
-284.83%
-299.06%
0.0%
0.0%
0.0%
PAT Margin
-49.55%
-240.19%
-377.01%
-352.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 190.76% vs 48.15% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 40.03% vs 5.67% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 59.34% vs 23.38% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 7.55% vs 26.19% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Mabpharm Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
279.98
2,699.71
-2,419.73
-89.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
279.98
2,699.71
-2,419.73
-89.63%
Raw Material Cost
93.56
1,573.21
-1,479.65
-94.05%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
77.98
643.94
-565.96
-87.89%
Power Cost
0
0
0.00
Manufacturing Expenses
11.44
33.44
-22.00
-65.79%
Selling and Distribution Expenses
244.09
172.51
71.58
41.49%
Other Expenses
-1.73
-67.74
66.01
97.45%
Total Expenditure (Excl Depreciation)
409.73
1,745.72
-1,335.99
-76.53%
Operating Profit (PBDIT) excl Other Income
-129.75
953.98
-1,083.73
-113.60%
Other Income
2.18
96.17
-93.99
-97.73%
Operating Profit (PBDIT)
-61.08
1,851.11
-1,912.19
-103.30%
Interest
11.44
33.44
-22.00
-65.79%
Exceptional Items
0.29
-45.41
45.70
100.64%
Gross Profit (PBDT)
186.42
1,126.49
-940.07
-83.45%
Depreciation
66.49
800.96
-734.47
-91.70%
Profit Before Tax
-138.72
971.30
-1,110.02
-114.28%
Tax
0.00
-10.27
10.27
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-138.72
976.44
-1,115.16
-114.21%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-138.72
976.44
-1,115.16
-114.21%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
5.13
-5.13
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-138.72
981.57
-1,120.29
-114.13%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
94.64
9,606.37
-9,511.73
-99.01%
Earnings per share (EPS)
-0.03
0.24
-0.27
-112.50%
Diluted Earnings per share
-0.03
0.24
-0.27
-112.50%
Operating Profit Margin (Excl OI)
-46.34%
35.34%
0.00
-81.68%
Gross Profit Margin
-25.80%
65.65%
0.00
-91.45%
PAT Margin
-49.55%
36.17%
0.00
-85.72%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 28.00 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 190.76% vs 48.15% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -13.87 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 40.03% vs 5.67% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -6.33 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 59.34% vs 23.38% in Dec 2023
Annual - Interest
Interest 1.14 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 7.55% vs 26.19% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -46.34%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






